<DOC>
	<DOCNO>NCT00379366</DOCNO>
	<brief_summary>Although ionize radiation propose prevention intimal hyperplasia coronary peripheral artery , information lack irradiation may prevent neointimal smooth-muscle cell proliferation restenosis prosthetic haemodialysis vascular access . We assess preventive effect one dose radiation ( 14 Gy ) administer transcutaneously one day dilatation stenosis prosthetic haemodialysis vascular access randomize control trial standardize clinical ultrasonographic one-year follow-up .</brief_summary>
	<brief_title>External Ionizing Radiation Prevent Restenosis Haemodialysis Vascular Access</brief_title>
	<detailed_description>Background : one major clinical concern prosthetic haemodialysis access risk possible restenosis stenosis dilatation . Only 25 % dilate prosthetic haemodialysis vascular access remain patent one year . No available pharmacological agent yet effectively prevent . After stenosis dilatation vascular wall respond mechanical injury standardize manner : intimal smooth-muscle cell migrate proliferate , neointima gradually begin form cell phenotype change contractile secretory . One way inhibit neointimal proliferation responsible restenosis induce cell apoptosis deliver ionize radiation dilate area endovascular procedure . Experimental study multicenter clinical trial report beneficial effect endovascular beta gamma ionize radiation vascular restenosis . Experimental study animal recent clinical trial clearly show external irradiation also reduce neointimal proliferation arterial injury thus open way clinical assessment ionize radiation artery . In previous experimental study , report irradiation dose-dependent effect prevention restenosis : dose large 10 Gy need obtain significant reduction intimal hyperplasia . Objective : main objective ass external ionizing radiation restenosis prevention prosthetic haemodialysis vascular access angioplasty . A secondary objective ass treatment safety . Methods : Single blind randomized clinical trial two parallel group 53 patient . Patients chronic renal failure treat dialysis include successful angioplasty stenosis vein adjacent prosthetic haemodialysis vascular access . One group treat single dose ionize radiation ( 14 Gy ) day 1 angioplasty . The control group receive preventive treatment . The primary outcome one-year vascular access patency failure . Secondary outcome one-year delay occurrence restenosis treatment safety . Outcomes assessed clinical ultrasonographic ( 1 , 3 , 6 12 month , time point case stenosis suspicion ) follow-up .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Graft Occlusion , Vascular</mesh_term>
	<criteria>18 year successful angioplasty ( residual stenosis &lt; 30 % ) significant stenosis ( maximal systolic speed 3 time &gt; basal maximal systolic speed , stenosis &gt; 70 % angiography ) venousprosthesis anastomosis venous segment 5 cm anastomosis prosthetic haemodialysis vascular access ( least 1 month old ) social security affiliation sign informed consent contraindication radiotherapy angioplasty stenting</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Randomized Controlled Trials</keyword>
	<keyword>Renal Dialysis</keyword>
	<keyword>Graft Occlusion , Vascular</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Vascular Patency</keyword>
	<keyword>Radiation , Ionizing</keyword>
</DOC>